• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

The American Skin Association Announces 2024 Funding Opportunities for Dermatology Researchers

News
Article

The submission deadline for this year’s awards and grants is Friday, March 15, 2024. Award recipients will be notified in June 2024, and the grant period for all awards is 1 year beginning on July 1, 2024.

Krakenimages.com/AdobeStock

Krakenimages.com/AdobeStock

The American Skin Association (ASA) recently announced its 2024 funding opportunities for researchers and physicians in dermatology.

"ASA is proud to announce that the 2024 grant opportunities to support medical and educational initiatives total nearly $750,000, which is the largest offering to date," said ASA Chairman Howard P. Milstein in a news release.1

"For nearly 40 years, ASA has funded hundreds of grants which have resulted in critical discoveries in various skin diseases."

The 2024 funding opportunities are as follows:

  • ASA Sanofi Investigative Scientist Award in Atopic Dermatitis ($100,000)
  • ASA Bristol Myers Squibb Investigative Scientist Award in Psoriasis & Related Biology ($100,000)
  • ASA Sun Pharma Investigative Scientist Award ($100,000)
  • ASA Calder Research Scholar Award in Vitiligo/Pigment Cell Disorders ($60,000)
  • ASA Incyte Research Scholar Award in Vitiligo/Pigment Cell Disorders ($60,000)
  • ASA Research Scholar Award in Atopic Dermatitis ($60,000)
  • ASA Janssen Research Scholar Award in Psoriasis & Related Biology ($60,000)
  • ASA Mulvaney Family Foundation Research Grant in Vitiligo/Pigment Cell Disorders ($15,000)
  • ASA Bristol Myers Squibb Research Grant in Psoriasis & Related Biology ($15,000)
  • ASA Arcutis Biotherapeutics Research Grant in Psoriasis & Related Biology ($15,000)
  • ASA Leo Pharma Research Grant in Atopic Dermatitis (3) ($15,000)
  • ASA La Roche-Posay Research Grant in Melanoma and Skin Cancer ($15,000)
  • ASA Bristol Myers Squibb Medical Student Grant in Psoriasis & Related Biology ($7,000)

Guidelines and applications can be found online at americanskin.org. The submission deadline is Friday, March 15, 2024, at 11:59 PM EST. Award recipients will be notified in June 2024 and the grant period for all awards is 1 year beginning on July 1, 2024.

"ASA looks forward to continuing its mission of funding high quality research that not only expands the field of dermatology, but also increases the quality of life for those that suffer from skin disease," said David A. Norris, MD, president of ASA. "These grants make a big difference for young investigators to help create momentum and progress in their research labs."

If you are interested in applying for ASA's 2024 funding opportunities, visit americanskin.org. Common questions among grant seekers have been answered on ASA's FAQ page. Questions concerning grant offerings or applications may be sent to ASA at grants@americanskin.org.

Impact of Former Grants

Last year, 15 grant recipients utilized research dollars to delve into understanding numerous disease states, including:

  • Nicholas Gulati, MD, PhD, assistant professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York, who won the 2023 ASA Daneen & Charles Stiefel Investigative Scientist Award for Melanoma Research to better understand the use of topical diphencyprone to improve efficacy of checkpoint inhibition in patients with melanoma.
  • Kingsley Essien, PhD, an instructor in the department of dermatology at the University of Massachusetts Chan Medical School, who won the 2023 ASA Calder Research Scholar Award in Vitiligo/Pigment Cell Disorders to investigated the suppressive mechanisms that autoreactive T-cells overwhelm to cause vitiligo, and identified signaling pathways that regulatory T-cells use to suppress T-cell-mediated depigmentation in a mouse model of disease.
  • Victoria Jimenez, a medical student at the University of Alabama at Birmingham, who won the 2023 ASA David Mandelbaum Medical Student Grant Targeting Skin Cancer and Melanoma to investigate the Posttranscriptional Regulation of Melanoma.

To see a full list of ASA grant recipients dating back to 1996, click here.2

References

  1. American Skin Association announces its 2024 funding opportunities for skin cancer & diseases. News release. February 2, 2024. Accessed February 5, 2024. https://prnmedia.prnewswire.com/news-releases/american-skin-association-announces-its-2024-funding-opportunities-for-skin-cancer--diseases-302052429.html
  2. American Skin Association. 2023 award and grant recipients. Accessed February 5, 2024. https://www.americanskin.org/research/recipients.php
Related Videos
© 2024 MJH Life Sciences

All rights reserved.